Loading…
TuHURA Biosciences, Inc. is projected to rise to $2.38 by 2027, a +10% move from its current price of $2.17. HURA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $2.09 | $2.17 | $2.25 | -0.06% |
| Aug 5 | $2.06 | $2.17 | $2.28 | -0.13% |
| Aug 6 | $2.03 | $2.17 | $2.31 | -0.19% |
| Aug 7 | $2.01 | $2.16 | $2.33 | -0.26% |
| Aug 8 | $1.99 | $2.16 | $2.35 | -0.32% |
| Aug 9 | $1.97 | $2.16 | $2.37 | -0.38% |
| Aug 10 | $1.96 | $2.16 | $2.38 | -0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.96 | $2.16 | $2.38 | -0.45% |
| Week 2 | $1.87 | $2.15 | $2.47 | -0.89% |
| Week 3 | $1.81 | $2.14 | $2.54 | -1.34% |
| Week 4 | $1.75 | $2.13 | $2.59 | -1.78% |
| Week 5 | $1.70 | $2.12 | $2.64 | -2.22% |
| Week 6 | $1.66 | $2.11 | $2.69 | -2.65% |
| Week 7 | $1.62 | $2.10 | $2.73 | -3.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TuHURA Biosciences, Inc. is a clinical stage immuno-oncology company that develops novel technologies for the treatment of cancer immunotherapies. Its lead product candidate is IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
The company is preparing to initiate a Phase 3 randomized placebo-controlled trial of IFx-2.0 administered as an adjunctive therapy to Keytruda. It also pursues Delta receptor technology to develop tumor microenvironment modulators as first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells.
Formerly Morphogenesis, Inc., the company changed its name to TuHURA Biosciences, Inc. in December 2023. It was founded in 1995 and is based in Tampa, Florida. TuHURA operates as a subsidiary of CohBar, Inc.
TuHURA Biosciences, Inc. trades at $2.04 per share and has a market cap of $129.91M, with a rank of 4056. The stock’s current price is paired with a long-horizon forecast that shows upside potential, including multi-year targets for average price and associated ROI.
The year-by-year forecast indicates gradual upside, with the average price rising from $2.04 in 2026 to $3.38 by 2030, $5.60 by 2040, and $11.62 by 2050. The forecast also provides a min/max band for each year, illustrating a path of potential appreciation alongside bullish sentiment in later years.
By 2030 the avg price is projected at $3.38 with a 65.5% ROI, by 2040 at $5.60 with a 174.7% ROI, and by 2050 at $11.62 with a 469.8% ROI, underscoring a long-run bullish outlook despite near-term uncertainty.
A major floor 35.0% below — a decisive break under it would weaken the trend.
The nearest floor, 6.0% below — buyers have tended to step in here.
The nearest ceiling, 24.9% above — a clean break opens room to run.
A major ceiling 45.2% above — clearing it would confirm fresh momentum.
Key HURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.14 | Buy | $2.15 | Buy |
| MA 10 | $2.17 | Buy | $2.17 | Sell |
| MA 20 | $2.24 | Sell | $2.22 | Sell |
| MA 50 | $2.28 | Sell | $2.25 | Sell |
| MA 100 | $2.25 | Sell | $2.16 | Buy |
| MA 200 | $1.84 | Buy | $2.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.18 | Neutral |
| Stoch RSI (14) | 58.57 | Neutral |
| CCI (20) | -62.15 | Neutral |
| Williams %R (14) | -61.76 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -4.82 | Sell |
| Bollinger %B (20,2) | 0.32 | Neutral |
| Stochastic %K (14) | 38.24 | Neutral |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 40.63 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 2.11 | Buy |
| ADX (14) | 10.15 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is neutral. RSI(14) is 40, indicating neither overbought nor oversold conditions. The near-term moving averages show a slightly higher resistance than current price, with SMA50 listed at $2.30 and SMA200 at $1.85, placing near-term support at $2.04 and a resistance at $2.71.
The stock’s 30-day price range spans from $1.60 to $2.61, highlighting a modest upside potential within the month. Annualized volatility sits at 70%, indicating relatively high swing risk relative to peers.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.44 | $2.17 | $2.66 | 0% | Neutral | |
| $1.84 | $2.38 | $3.30 | +10% | Neutral | |
| $2.03 | $2.74 | $3.99 | +26% | Bullish | |
| $2.38 | $3.32 | $5.01 | +53% | Bullish | |
| $2.47 | $3.54 | $5.52 | +63% | Bullish | |
| $2.28 | $3.36 | $5.39 | +55% | Bullish | |
| $2.44 | $3.70 | $6.07 | +71% | Bullish | |
| $2.30 | $3.57 | $5.99 | +65% | Bullish | |
| $2.30 | $3.66 | $6.26 | +69% | Bullish | |
| $3.20 | $5.20 | $9.05 | +140% | Bullish | |
| $3.18 | $5.72 | $10.75 | +164% | Bullish | |
| $5.46 | $11.86 | $24.87 | +447% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.44 | $2.17 | $2.67 | +0.00% |
| September 2026 | $1.83 | $2.19 | $2.71 | +0.93% |
| October 2026 | $1.70 | $2.05 | $2.57 | -6.54% |
| November 2026 | $1.64 | $2.00 | $2.53 | -2.48% |
| December 2026 | $1.70 | $2.08 | $2.66 | +4.00% |
Click any year to see its month-by-month HURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HURA price prediction for 2026 points to an average of $2.17 (low $0.44, high $2.66) — a potential gain of 0% on today's $2.17. A consolidation phase looks the most probable path here.
In 2027, HURA is projected to trade between $1.84 and $3.30, averaging $2.38 — a potential gain of +10% from today's $2.17. That is up +10% on the projected 2026 average. Price action looks broadly range-bound.
TuHURA Biosciences, Inc.'s 2028 outlook centres on $2.74, within a $2.03 to $3.99 range. That is up +15% on the projected 2027 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, HURA could reach as high as $5.01, with a base case around $3.32 and support toward $2.38 — roughly +53% from $2.17. Momentum favours further upside here.
Expect HURA to range from $2.47 to $5.52 through 2030. The $3.54 average target implies a +63% move from current prices. That is up +7% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The HURA price prediction for 2031 points to an average of $3.36 (low $2.28, high $5.39) — a potential gain of +55% on today's $2.17. Momentum favours further upside here.
In 2032, HURA is projected to trade between $2.44 and $6.07, averaging $3.70 — a potential gain of +71% from today's $2.17. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
TuHURA Biosciences, Inc.'s 2033 outlook centres on $3.57, within a $2.30 to $5.99 range. That is -4% versus the projected 2032 average. That marks a +65% change versus current levels. Momentum favours further upside here.
By 2034, HURA could reach as high as $6.26, with a base case around $3.66 and support toward $2.30 — roughly +69% from $2.17. Buyers look set to stay in control over this stretch.
Expect HURA to range from $3.20 to $9.05 through 2035. The $5.20 average target implies a +140% move from current prices. That is up +42% on the projected 2034 average. Momentum favours further upside here.
The HURA price prediction for 2040 points to an average of $5.72 (low $3.18, high $10.75) — a potential gain of +164% on today's $2.17. Buyers look set to stay in control over this stretch.
In 2050, HURA is projected to trade between $5.46 and $24.87, averaging $11.86 — a potential gain of +447% from today's $2.17. That is up +107% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HURA today (≈ 460.829493 HURA) could be worth
$5,467.28
+$4,467.28 (+447%) by 2050 · US Dollar
Based on the average projected HURA price of $11.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HURAwould be worth at today's price.
$1,000 invested in HURA on Jul 31, 2025 (≈ 403.225803 HURA) would be worth
$875
-$125 (-12.5%) today · 0.87× · US Dollar
Based on a HURA entry price of $2.48 vs. today's $2.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.11 | $1,028.44 | +2.8% |
| 1 month ago | $2.45 | $885.71 | -11.4% |
| 3 months ago | $2.33 | $931.33 | -6.9% |
| 6 months ago | $0.519 | $4,181.12 | +318.1% |
| 1 year ago | $2.48 | $875 | -12.5% |
| All time (5.0y) ago | $2,590 | $0.84 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HURA forecast.
Our base-case forecast reaches $4.30 around 2035.
Implied market cap at $4.30: $273.83M
Longer-horizon forecasts point to sustained upside with a bullish tilt. By 2030, the average forecast price is $3.38 and the max is $5.26, yielding a 65.5% ROI on the midpoint. The 2040 forecast shows an average of $5.60 and a max of $10.53 with a 174.7% ROI, while 2050 projects an average of $11.62 and a max of $24.35 with a 469.8% ROI.
These multi-year targets imply meaningful appreciation from today’s level if achieved, with a sequence of higher annual averages and notable upside in the far horizon. The risks include market variability and execution milestones across the company’s pipeline. Remember, these are estimates and not guarantees.
Tap a question to reveal the answer.
Avg price $3.38, min $2.35, max $5.26; ROI 65.5%; sentiment BULLISH.
Current price $2.04; Market cap $129.91M.
2031 forecast: avg $3.24, max $5.19, min $2.20; ROI 59%; sentiment BULLISH.
30-day range is $1.60 to $2.61.
Avg $11.62, min $5.36, max $24.35; ROI 469.8%; sentiment BULLISH.
TuHURA Biosciences, Inc. Community Discussion
0Share your TuHURA Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.